Phase IB study of vemurafenib in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with BRAFV600E mutation. Cancer Discov. 2016; 6: 1352–1365. doi: 10.1158/2159-8290
作者： DS Hong , VK Morris , B El Osta , AV Sorokin , F Janku
DOI:
关键词:
